BIOPOLE, EPALINGES, V8
Reports First Quarter 2026 Financial Results and Provides Operational Updates
Annual Report to Security Holders
Financial Results, Press Release
ADC Therapeutics Enters Amendment to Material Definitive Agreement
Corporate Presentation January 2026
Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates
Other Events
Reports Third Quarter 2025 Financial Results and Provides Operational Update
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Amended Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence